Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia

J Infect. 2022 Dec;85(6):644-651. doi: 10.1016/j.jinf.2022.09.017. Epub 2022 Sep 22.

Abstract

Objective: To construct a prediction model for bacteraemia in patients with pneumococcal community-acquired pneumonia (P-CAP) based on variables easily obtained at hospital admission.

Methods: This prospective observational multicentre derivation-validation study was conducted in patients hospitalised with P-CAP between 2000 and 2020. All cases were diagnosed based on positive urinary antigen tests in the emergency department and had blood cultures taken on admission. A risk score to predict bacteraemia was developed.

Results: We included 1783 patients with P-CAP (1195 in the derivation and 588 in the validation cohort). A third (33.3%) of the patients had bacteraemia. In the multivariate analysis, the following were identified as independent factors associated with bacteraemia: no influenza vaccination the last year, no pneumococcal vaccination in the last 5 years, blood urea nitrogen (BUN) ≥30 mg/dL, sodium <130 mmol/L, lymphocyte count <800/µl, C-reactive protein ≥200 mg/L, respiratory failure, pleural effusion and no antibiotic treatment before admission. The score yielded good discrimination (AUC 0.732; 95% CI: 0.695-0.769) and calibration (Hosmer-Lemeshow p-value 0.801), with similar performance in the validation cohort (AUC 0.764; 95% CI:0.719-0.809).

Conclusions: We found nine predictive factors easily obtained on hospital admission that could help achieve early identification of bacteraemia. The prediction model provides a useful tool to guide diagnostic decisions.

Keywords: Bacteraemia; Pneumococcal pneumonia; Prediction model.

Publication types

  • Observational Study
  • Multicenter Study

MeSH terms

  • Bacteremia* / epidemiology
  • Blood Culture
  • Hospitalization
  • Humans
  • Pneumonia, Pneumococcal* / complications
  • Pneumonia, Pneumococcal* / epidemiology
  • Streptococcus pneumoniae